Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trialJun Tian, Ryan B. Corcoran, Marios Giannakis et al.|Nature Medicine|2023Cited by 197
SO-26 Clinical efficacy of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patientsRyan B. Corcoran, Aparna R. Parikh, Marios Giannakis et al.|Annals of Oncology|2020Cited by 43